Loading clinical trials...
Loading clinical trials...
The purpose of this study is to determine if treatment with the ELAD Bioartificial Liver Assist Device is beneficial to patients in Acute Liver Failure either as a bridge to liver transplant or bridge...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Vital Therapies, Inc.
NCT06594237 · Fulminant Hepatic Failure
NCT00518440 · Acute Liver Failure, Fulminant Hepatic Failure, and more
NCT01875874 · Acute Liver Failure, Fulminant Hepatic Failure, and more
NCT00832728 · Fulminant Hepatic Failure
UCSD
San Diego, California
University of Miami
Miami, Florida
Emory School of Medicine
Atlanta, Georgia
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions